177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo
- 7 April 2005
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (3) , 269-278
- https://doi.org/10.1016/j.nucmedbio.2005.01.003
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- In vitro Toxicity of A-431 Carcinoma Cells with Antibodies to Epidermal Growth Factor Receptor and Epithelial Glycoprotein-1 Conjugated to Radionuclides Emitting Low-Energy ElectronsClinical Cancer Research, 2004
- In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applicationsNuclear Medicine and Biology, 2002
- Radionuclide-antibody conjugates for single-cell cytotoxicityCancer, 2002
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumorsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s LymphomasJournal of Clinical Oncology, 2001
- Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic LigandsNuclear Medicine and Biology, 1998
- Quantitation of Target Molecules from Polymerase Chain Reaction-Based Limiting Dilution AssaysAIDS Research and Human Retroviruses, 1997
- Radioassays of yttrium-90 used in nuclear medicineNuclear Medicine and Biology, 1993
- scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair.Proceedings of the National Academy of Sciences, 1991